Publicacións en colaboración con investigadores/as de Hospital Universitario Lucus Augusti (19)

2024

  1. Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97

2023

  1. Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  2. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

  3. The three-noes right-sided infective endocarditis: An unrecognized type of right-sided endocarditis

    Medicine, Vol. 102, Núm. 29, pp. e34322

2022

  1. Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing

    PLoS ONE, Vol. 17, Núm. 2 February

  2. Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing

    Journal of Clinical Medicine, Vol. 11, Núm. 20

2021

  1. Comparison of One-Year Outcomes Between the ihtDEStiny BD Stent and the Durable-Polymer Everolimus- and Zotarolimus-Eluting Stents: A Propensity-Score-Matched Analysis

    Cardiovascular Revascularization Medicine, Vol. 31, pp. 1-6

2020

  1. Assessment of coronary microvascular dysfunction: An integral part of risk-stratification in Takotsubo cardiomyopathy - A response

    Journal of Cleaner Production

  2. Efectos de la pandemia de COVID-19 sobre la población mayor de 75 años con revascularización coronaria previa: Subanálisis del registro EPIC SIERRA 75

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 321-322

  3. Full scaffold jacket for spontaneous coronary artery dissection of left anterior descending artery with magnesium reabsorbable scaffolds: 1 year follow-up

    Coronary Artery Disease

  4. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002

  5. Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study

    Arthritis Care and Research, Vol. 72, Núm. 6, pp. 822-828

  6. Magmaris very late in-scaffold restenosis: Has the “black boxes” nightmare come back?

    Catheterization and Cardiovascular Interventions, Vol. 96, Núm. 2, pp. E174-E176

  7. Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design

    American Heart Journal, Vol. 222, pp. 174-182

2019

  1. Bioresorbable magnesium scaffold in complex PCI in a nickel allergy patient: one-year follow-up - no disease, no scaffolds

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 15, Núm. 7, pp. 640-641

  2. Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study

    Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360

2018

  1. Feasibility of use of magnesium reabsorbable scaffolds in complex coronary artery disease: True bifurcation, multiple overlapping scaffolds and chronic total occlusion treatment

    Revista Portuguesa de Cardiologia, Vol. 37, Núm. 12, pp. 1009.e1-1009.e3

2015

  1. Gender differences in patients with atrial fibrillation undergoing electrical cardioversion

    Journal of Women's Health, Vol. 24, Núm. 6, pp. 466-470

  2. Is the homeostatic model assessment of insulin resistance a poor predictor of cardiovascular disease in rheumatoid arthritis? Comment on the Article by Giles et al

    Arthritis and Rheumatology